Retrospective Multicenter Analysis of Prognostic Risk Factors for One Year Recurrence in Patient With Renal Cell Carcinoma After Partial or Radical Nephrectomy: Results of Korean Renal Cancer Study Group (KRoCS) Database-Reference-Cited by-同舟云学术

Retrospective Multicenter Analysis of Prognostic Risk Factors for One Year Recurrence in Patient With Renal Cell Carcinoma After Partial or Radical Nephrectomy: Results of Korean Renal Cancer Study Group (KRoCS) Database

Published:2024 Issue:3 Volume:39 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Choi Changil¹^ORCID,Kang Minyong²^ORCID,Seo Seong Il²^ORCID,Suh Jungyo³^ORCID,Song Cheryn³^ORCID,Chung Jinsoo⁴^ORCID,Kim Sung Han⁴^ORCID,Park Jae Young⁵^ORCID,Hwang Eu Chang⁶^ORCID,Jeong Chang Wook⁷^ORCID,Kwak Cheol⁷^ORCID,Kim Jung Kwon⁸^ORCID,Hong Sung-Hoo⁹^ORCID

Affiliation:

1. Department of Urology, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.

2. Department of Urology, Samsung Medical Center, Seoul, Korea.

3. Department of Urology, Asan Medical Center, Seoul, Korea.

4. Department of Urology, National Cancer Center, Goyang, Korea.

5. Department of Urology, Korea University College of Medicine, Korea University Ansan Hospital, Ansan, Korea.

6. Department of Urology, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Hwasun, Korea.

7. Department of Urology, Seoul National University Hospital, Seoul, Korea.

8. Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea.

9. Department of Urology, The Catholic University of Korea, Seoul St. Mary’s Hospital, Seoul, Korea.

Publisher

XMLink

Subject

General Medicine

Link

https://jkms.org/pdf/10.3346/jkms.2024.39.e11

Reference22 articles.

1. Epidemiology of Renal Cell Carcinoma: 2022 Update

2. Beyond gastric adenocarcinoma: Multimodality assessment of common and uncommon gastric neoplasms

3. Risk‐adjusted proposal for >60 months follow up after surgical treatment of organ‐confined renal cell carcinoma according to life expectancy

4. Risk Group Assessment and Clinical Outcome Algorithm to Predict the Natural History of Patients With Surgically Resected Renal Cell Carcinoma

5. Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study